Accelidea - About the company
Accelidea is an unfunded company based in Quincy (United States), founded in 2023. It operates as a Cloud-based AI platform automating medical device design and compliance processes. Accelidea has not raised any funding yet. The company has 24 active competitors, including 8 funded and 1 that has exited. Its top competitors include companies like Apprentice, Aizon and H3D.
Company Details
Cloud-based AI platform automating medical device design and compliance processes. It automates the medical device design and compliance processes, providing a one-click submission experience from concept to market.
Key Metrics
Founded Year
2023
Location
Quincy, United States
Stage
Unfunded
Ranked
24th among 24 active competitors
Similar Companies
Sign up to download Accelidea's company profile
Accelidea's funding and investors
Accelidea has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Accelidea's Competitors and alternates
Top competitors of Accelidea include Apprentice, Aizon and H3D. Here is the list of Top 10 competitors of Accelidea, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ![]() Apprentice 2003, Boston (United States), Series C | AI-based manufacturing processing and management tool for pharmaceutical industry | $247M | 58/100 | |
2nd | Aizon 2014, San Francisco (United States), Series C | Provider of AI-based software for manufacturing operations | $44.6M | 57/100 | |
3rd | Provider of software to manufacturers and labs custom-fit businesses | $6.8M | 56/100 | ||
4th | Leucine 2015, Wilmington (United States), Series A | Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory | $7.67M | 50/100 | |
5th | Helical 2023, Luxembourg (Luxembourg), Seed | Open-source platform for researchers to accelerate drug development | $2.35M | 44/100 | |
6th | Provider of AI-based planning solutions for the pharmaceutical industries | $7.09M | 41/100 | ||
7th | Seal 2019, London (United Kingdom), Seed | AI-powered platform that automates the workflow in pharma companies and research labs | $125K | 40/100 | |
8th | POMS 1987, Herndon (United States), Acquired | Developer of manufacturing execution system software for the life science sector | - | 37/100 | |
9th | Katalyze AI 2023, Toronto (Canada), Unfunded | Provider of a cloud-based biopharmaceutical manufacturing software | - | - | 29/100 |
10th | Enzyme Technology 2023, Pudong (China), Seed | Provider of AI-based enzymatic DNA synthesis technology | - | 27/100 | |
24th | Accelidea 2023, Quincy (United States), Unfunded | Cloud-based AI platform automating medical device design and compliance processes | - | - | 16/100 |
Looking for more details on Accelidea's competitors? Click here to see the top ones
Accelidea's Investments and acquisitions
Accelidea has made no investments or acquisitions yet.
Reports related to Accelidea
Here is the latest report on Accelidea's sector:
Are you a Founder ?
FAQs about Accelidea
Explore our recently published companies
- Happytrucker.com - 2014 founded, Unfunded company
- Tibair - Hyderabad based, 1998 founded, Unfunded company
- Kleen Bill - 2023 founded, Unfunded company
- Yoshidot AB - Bollebygd based, 2006 founded, Unfunded company
- EnviroNet Pvt - India based, Unfunded company
- Innokas - Kempele based, 1994 founded, Unfunded company

